首页> 外文期刊>Journal of biomolecular techniques :JBT. >Variant identification in multi-sample pools by illumina genome analyzer sequencing.
【24h】

Variant identification in multi-sample pools by illumina genome analyzer sequencing.

机译:通过照明基因组分析仪测序在多样品池中进行变异鉴定。

获取原文
获取原文并翻译 | 示例
           

摘要

Multi-sample pooling and Illumina Genome Analyzer (GA) sequencing allows high throughput sequencing of multiple samples to determine population sequence variation. A preliminary experiment, using the RET proto-oncogene as a model, predicted ≤ 30 samples could be pooled to reliably detect singleton variants without requiring additional confirmation testing. This report used 30 and 50 sample pools to test the hypothesized pooling limit and also to test recent protocol improvements, Illumina GAIIx upgrades, and longer read chemistry. The SequalPrep(TM) method was used to normalize amplicons before pooling. For comparison, a single 'control' sample was run in a different flow cell lane. Data was evaluated by variant read percentages and the subtractive correction method which utilizes the control sample. In total, 59 variants were detected within the pooled samples, which included all 47 known true variants. The 15 known singleton variants due to Sanger sequencing had an average of 1.62 ± 0.26% variant reads for the 30 pool (expected 1.67% for a singleton variant [unique variant within the pool]) and 1.01 ± 0.19% for the 50 pool (expected 1%). The 76 base read lengths had higher error rates than shorter read lengths (33 and 50 base reads), which eliminated the distinction of true singleton variants from background error. This report demonstrated pooling limits from 30 up to 50 samples (depending on error rates and coverage), for reliable singleton variant detection. The presented pooling protocols and analysis methods can be used for variant discovery in other genes, facilitating molecular diagnostic test design and interpretation.
机译:多样品池和Illumina基因组分析仪(GA)测序可对多个样品进行高通量测序,以确定群体序列变异。以RET原癌基因为模型的初步实验,可以合并预测的≤30个样本,以可靠地检测单例变体,而无需其他确认测试。该报告使用了30个和50个样本池来测试假设的池限制,并测试最近的协议改进,Illumina GAIIx升级和更长的读取化学过程。在合并之前,使用SequalPrep TM方法对扩增子进行归一化。为了进行比较,在不同的流通池通道中运行了一个“对照”样品。通过变体读取百分比和利用对照样品的减法校正方法评估数据。在合并的样本中总共检测到59个变体,其中包括所有47个已知的真实变体。 Sanger测序导致的15个已知单例变体的30个库平均有1.62±0.26%的变体读数(单例变体(库中的唯一变体)预期为1.67%)和50个库的1.01±0.19%(预期) 1%)。 76个碱基的阅读长度比较短的阅读长度(33和50个碱基阅读)具有更高的错误率,这消除了真正的单例变体与背景错误的区别。该报告展示了从30到50个样本的合并限制(取决于错误率和覆盖率),以实现可靠的单例变体检测。提出的合并方案和分析方法可用于其他基因的变异发现,从而促进分子诊断测试的设计和解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号